MedKoo Cat#: 584779 | Name: Meproadifen

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Meproadifen enhances activation and desensitization of the acetylcholine receptor-ionic channel complex (AChR).

Chemical Structure

Meproadifen
Meproadifen
CAS#70147-13-6

Theoretical Analysis

MedKoo Cat#: 584779

Name: Meproadifen

CAS#: 70147-13-6

Chemical Formula: C24H34NO2+

Exact Mass: 368.2584

Molecular Weight: 368.54

Elemental Analysis: C, 78.22; H, 9.30; N, 3.80; O, 8.68

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Meproadifen
IUPAC/Chemical Name
Ethanaminium, N,N-diethyl-N-methyl-2-((1-oxo-2,2-diphenylpentyl)oxy)-
InChi Key
WZNYPLOXSJKIMK-UHFFFAOYSA-N
InChi Code
InChI=1S/C24H34NO2/c1-5-18-24(21-14-10-8-11-15-21,22-16-12-9-13-17-22)23(26)27-20-19-25(4,6-2)7-3/h8-17H,5-7,18-20H2,1-4H3/q+1
SMILES Code
CCCC(C1=CC=CC=C1)(C2=CC=CC=C2)C(OCC[N+](CC)(CC)C)=O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 368.54 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Pedersen SE, Sharp SD, Liu WS, Cohen JB. Structure of the noncompetitive antagonist-binding site of the Torpedo nicotinic acetylcholine receptor. [3H]meproadifen mustard reacts selectively with alpha-subunit Glu-262. J Biol Chem. 1992 May 25;267(15):10489-99. PubMed PMID: 1587830. 2: Maleque MA, Souccar C, Cohen JB, Albuquerque EX. Meproadifen reaction with the ionic channel of the acetylcholine receptor: potentiation of agonist-induced desensitization at the frog neuromuscular junction. Mol Pharmacol. 1982 Nov;22(3):636-47. PubMed PMID: 6296656. 3: Aracava Y, Albuquerque EX. Meproadifen enhances activation and desensitization of the acetylcholine receptor-ionic channel complex (AChR): single channel studies. FEBS Lett. 1984 Sep 3;174(2):267-74. PubMed PMID: 6088290. 4: Dreyer EB, Hasan F, Cohen SG, Cohen JB. Reaction of [3H]meproadifen mustard with membrane-bound Torpedo acetylcholine receptor. J Biol Chem. 1986 Oct 15;261(29):13727-34. PubMed PMID: 3759990. 5: Arias HR. Topology of ligand binding sites on the nicotinic acetylcholine receptor. Brain Res Brain Res Rev. 1997 Oct;25(2):133-91. Review. PubMed PMID: 9403137. 6: Neubig RR, Krodel EK, Boyd ND, Cohen JB. Acetylcholine and local anesthetic binding to Torpedo nicotinic postsynaptic membranes after removal of nonreceptor peptides. Proc Natl Acad Sci U S A. 1979 Feb;76(2):690-4. PubMed PMID: 34154; PubMed Central PMCID: PMC383020. 7: Ortells MO, Barrantes GE. Understanding channel blocking in the nicotinic acetylcholine receptor. Receptors Channels. 2001;7(4):273-88. PubMed PMID: 11697233. 8: Neubig RR, Cohen JB. Equilibrium binding of [3H]tubocurarine and [3H]acetylcholine by Torpedo postsynaptic membranes: stoichiometry and ligand interactions. Biochemistry. 1979 Nov 27;18(24):5464-75. PubMed PMID: 518850. 9: Arias HR. Binding sites for exogenous and endogenous non-competitive inhibitors of the nicotinic acetylcholine receptor. Biochim Biophys Acta. 1998 Aug 21;1376(2):173-220. Review. PubMed PMID: 9748559. 10: Bloch RJ. Loss of acetylcholine receptor clusters induced by treatment of cultured rat myotubes with carbachol. J Neurosci. 1986 Mar;6(3):691-700. PubMed PMID: 3958790. 11: Galzi JL, Revah F, Bouet F, Ménez A, Goeldner M, Hirth C, Changeux JP. Allosteric transitions of the acetylcholine receptor probed at the amino acid level with a photolabile cholinergic ligand. Proc Natl Acad Sci U S A. 1991 Jun 1;88(11):5051-5. PubMed PMID: 2052586; PubMed Central PMCID: PMC51805. 12: Arias HR. Luminal and non-luminal non-competitive inhibitor binding sites on the nicotinic acetylcholine receptor. Mol Membr Biol. 1996 Jan-Mar;13(1):1-17. Review. PubMed PMID: 9147657. 13: Boyd ND, Leeman SE. Multiple actions of substance P that regulate the functional properties of acetylcholine receptors of clonal rat PC12 cells. J Physiol. 1987 Aug;389:69-97. PubMed PMID: 2445982; PubMed Central PMCID: PMC1192071. 14: Pedersen SE, Dreyer EB, Cohen JB. Location of ligand-binding sites on the nicotinic acetylcholine receptor alpha-subunit. J Biol Chem. 1986 Oct 15;261(29):13735-43. PubMed PMID: 3093482. 15: Heidmann T, Oswald RE, Changeux JP. Multiple sites of action for noncompetitive blockers on acetylcholine receptor rich membrane fragments from torpedo marmorata. Biochemistry. 1983 Jun 21;22(13):3112-27. PubMed PMID: 6882740. 16: Bolger GT, Marcus KA, Daly JW, Skolnick P. Local anesthetics differentiate dihydropyridine calcium antagonist binding sites in rat brain and cardiac membranes. J Pharmacol Exp Ther. 1987 Mar;240(3):922-30. PubMed PMID: 3031279.